This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Health Stocks in Motion

Updated from 2:35 p.m. EDT

Shares of NBTY (NTY) were among the best-performing health and pharmaceutical stocks Monday, rising 11.9% after the company released preliminary fourth-quarter sales results.

The maker of nutritional supplements posted preliminary sales of $426 million, up significantly from the year-ago period, when it turned in sales of $365 million. Analysts polled by Thomson First Call were expecting fourth-quarter sales of $394.1 million. Shares of NBTY traded up $2.71 to $25.40.

Euro Tech Holdings (CLWT) rose 10.2% after the company signed two contracts to supply flow injection analyzers and sample preparation equipment for water quality analysis. The contracts, worth about $1.9 million, were awarded by the State Environmental Protection Agency of the People's Republic of China. The equipment will be supplied and installed in monitoring stations around various parts of China by the end of the year. Shares traded up 27 cents to $2.92.

Shares of Cytyc (CYTC) rose 5.4% after the company announced a multi-year deal with LabOne (LABS). The deal calls for Cytyc's ThinPrep Imaging Systems to be placed within a LabOne lab in the Kansas City area. The location is the highest volume, single-site testing lab in the country, Cytyc said. The ThinPrep system is used to improve cancer screening efficiency and performance. Shares traded up $1.30 to $25.23.

Johnson & Johnson (JNJ) traded actively after the company announced that its Ortho Biotech Products unit received a subpoena from the Office of the Inspector General for the Department of Health and Human Services. The subpoena for documents is related to the sales and marketing of Procrit, a treatment that's used for anemia. Johnson & Johnson said that it is cooperating with regulators. Shares traded up 25 cents to $57.25.

Other health care volume movers included Merck (MRK), up 92 cents to $34.23; Schering-Plough (SGP), down 45 cents to $18.50; Amgen (AMGN), down 13 cents to $57.63; Pfizer (PFE), up 33 cents to $31.30; and Genentech (DNA), up 83 cents to $53.99.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,001.22 -38.27 -0.22%
S&P 500 1,988.40 -3.97 -0.20%
NASDAQ 4,538.5510 +6.4470 0.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs